Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Head and Neck Surgery
NCT00147862Phase 3Completed
- Sponsor
- Tata Memorial Hospital
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in oral cavity squamous cell carcinoma (OCSCC) comparing Tranexamic Acid with Placebo (2 arms). Primary endpoints: Perioperative blood loss and Requirement for replacement of blood. Started May 2005; status: completed.
02
Drugs
tranexamic acid
03
Conditions
oral cavity squamous cell carcinoma (OCSCC)
Beyond the preview
Go deeper on NCT00147862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147862.